<p>Disclosed is a novel therapeutic agent for hepatitis C, which has a high therapeutic effect on hepatitis C. The therapeutic agent for hepatitis C comprises hydroxyurea as an active ingredient. The therapeutic agent for hepatitis C may additionally comprise interferon-a. The novel therapeutic agent for hepatitis C has a high therapeutic effect on hepatitis C. The use of interferon-a in combination can achieve a synergistic effect for the treatment of hepatitis C. When a patient is infected by a hepatitis C virus having a genotype on which interferon-a therapy is effective, the therapeutic effect on the patient can be further increased by using interferon-a in combination.</p>
申请公布号
WO2010044474(A1)
申请公布日期
2010.04.22
申请号
WO2009JP67942
申请日期
2009.10.16
申请人
PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY;NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY;NOZAKI, AKITO;TANAKA, KATSUAKI;IKEDA, MASANORI;KATO, NOBUYUKI